北京最好的哮喘医院小儿肺热咳喘口服液辅治支气管肺炎的临床研究

2020年11月9日发(作者：伍霖生)

小儿肺热咳喘口服液辅治支气管肺炎的临床研究
管达


【期刊名称】《中国医药科学》

【年(卷),期】2013(000)018

【摘要】目的：观察小儿肺热咳喘口服 液在支气管肺炎辅助治疗的疗效及安全
性。方法按照治疗方法将2010年10月～2012年10月入 院治疗支气管肺炎
的80例小儿患者分为两组，对照组40例静脉滴注头孢曲松钠，治疗组40例
在对照组基础上使用小儿肺热咳喘口服液辅助治疗，疗程均为5～7d。结果治
疗组小儿患者病情恢复 指标均好于对照组（P＜0.05）；治疗组有效率为95.0%
显著高于对照组有效率70.0%（P ＜0.05）；治疗组中有1例患儿出现胃部不良
反应，停药后病情恢复。结论支气管肺炎辅助小儿肺热 咳喘口服液治疗，疗效
显著，安全性好，临床应用前景广泛。%Objective To observe the efficacy
and safety of pediatric Feire Kechuan oral liquid in adjuvant treatment
of bronchial pneumonia. Methods According to the treatment method,
80 pediatric patients with bronchial pneumonia in our health-center
from October 2010 to October 2012 were divided into two groups, 40
cases of the control group were treated by intravenous drip of
ceftriaxone sodium, 40 cases of the treatment group were treated by
pediatric Feire Kechuan oral liquid adjuvant therapy based on the
treatment of control group, the course of treatment was 5-7 days.
Results The clinical progress indicator of pediatric patients in the
treatment group were better than the control group (P < 0.05).The